Quetiapine: uses, dosing, side effects & brands

SEROQUEL ® (quetiapine) is an atypical antipsychotic belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [ b,f ] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It is present in tablets as the fumarate salt. All doses and tablet strengths are expressed as milligrams of base, not as fumarate salt.

The FDA classifies quetiapine as an atypical antipsychotic. Atypical antipsychotics block dopamine D2 receptors and serotonin 5-HT2A receptors in the brain, rebalancing these signaling chemicals to reduce hallucinations, delusions, and mood symptoms in conditions like schizophrenia and bipolar disorder. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

The label reports that available data from published epidemiologic studies of pregnant women exposed to quetiapine have NOT established a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. However, it warns that neonates exposed to antipsychotics (including quetiapine) during the third trimester are at risk for extrapyramidal and/or withdrawal symptoms following delivery. A National Pregnancy Registry for Atypical Antipsychotics exists (1-866-961-2388). The label also notes the risks of untreated schizophrenia, bipolar I, or major depressive disorder in the mother. Discuss the decision to use, continue, or change treatment during pregnancy with your prescriber; do not start or stop on your own. This is what quetiapine's FDA label says; whether to use it in pregnancy is your prescriber's decision.

The label lists weight gain as an adverse reaction and as a class-related metabolic change (hyperglycemia, dyslipidemia, weight gain), and recommends regular monitoring of weight. In short-term placebo-controlled adult trials weight gain occurred in about 5-6% of quetiapine-treated patients vs 1% on placebo, with a dose-response relationship. The proportion of adults gaining at least 7% of body weight was markedly higher on quetiapine than placebo (e.g., 23% vs 6% in schizophrenia; 21% vs 7% in bipolar mania monotherapy). Mean weight change was about +2.0 kg (quetiapine) vs -0.4 kg (placebo) in a schizophrenia trial. In children/adolescents, increased appetite and weight increase were common, and after 26 weeks mean body-weight increase was 4.4 kg with 45% gaining at least 7% (not adjusted for normal growth).

The label addresses alcohol. In Drug Interactions it states that quetiapine potentiated the cognitive and motor effects of alcohol in a clinical trial in subjects with psychotic disorders, and that alcoholic beverages should be limited while taking quetiapine. The Medication Guide is more direct, telling patients not to drink alcohol while taking quetiapine because it may make some side effects worse. This is an additive CNS effect (impaired cognition and motor function), not a disulfiram-like reaction. This is what quetiapine's FDA label says; alcohol advice depends on your dose and health, so confirm with your pharmacist.

The label has a Discontinuation Syndrome section (5.19). It states that acute withdrawal symptoms - insomnia, nausea, and vomiting - have been described after abrupt cessation of atypical antipsychotics including quetiapine. In short-term trials with the XR formulation, an aggregate 12.1% of patients experienced one or more discontinuation symptoms after abrupt cessation (vs 6.7% on placebo), the named symptoms being insomnia, nausea, headache, diarrhea, vomiting, dizziness, and irritability, which usually resolved within about a week. The label states that gradual withdrawal is advised, meaning a prescriber-managed taper rather than abrupt stopping. This is not in the boxed warning (the boxed warning concerns increased mortality in elderly dementia patients and suicidality, not withdrawal). Do not stop quetiapine on your own — any change is a prescriber-managed decision.

The elimination half-life of quetiapine is about 6 hours — that is how long the body takes to clear half of a dose. The label reports a mean terminal elimination half-life of roughly 6 hours for the parent drug, with linear (dose-proportional) kinetics across the clinical dose range. Quetiapine's major active metabolite, norquetiapine (N-desalkylquetiapine), is pharmacologically active and outlasts the parent, with a longer terminal half-life of about 9 to 12 hours. Not a prodrug. Clearance falls in older adults (roughly 30-50% lower, effectively prolonging exposure) and in hepatic impairment (about 30% lower oral clearance), so lower starting doses are advised; renal impairment does not meaningfully change clearance. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run quetiapine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 3 quetiapine-containing products in the U.S.: Quetiapine Fumarate, Seroquel and Seroquel XR. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, quetiapine is currently marketed as tablet, extended release and tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 1 generic quetiapine product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Quetiapine has two very different timelines. Its sedating effect is fast — many people feel drowsy the first night — but the effect on mood, agitation or psychosis builds gradually, usually over several weeks of regular use. Feeling sleepy early does not mean the full benefit has arrived. Give it time, stay in touch with your prescriber about side effects, and do not stop it suddenly.

Alcohol: the FDA label says to avoid alcohol — see the alcohol section above for what it actually says. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

The most common side effect is drowsiness or sedation, which can be strong, especially when you first start or increase the dose. Other frequent effects, per MedlinePlus, include dizziness and feeling unsteady, dry mouth, constipation, increased appetite and weight gain, and lightheadedness when standing up quickly (nausea, indigestion, and a stuffy nose are also reported). Seroquel's sedation is why it's often taken at bedtime. This is not a complete list; tell your prescriber about any effect that bothers you or won't go away.

Seroquel (quetiapine) carries two FDA boxed warnings. First, elderly patients with dementia-related psychosis have an increased risk of death and should not take it for that use. Second, quetiapine and other antidepressant-class drugs can increase suicidal thoughts and behavior in children, teens, and young adults under 25 — watch closely for worsening mood or new suicidal thoughts, especially early on. Call 911 or go to the ER for signs of neuroleptic malignant syndrome, a rare emergency: MedlinePlus says get immediate help for "fever; stiff muscles; sweating; confusion; or fast, pounding, or irregular heartbeat." Also seek urgent care for a seizure, "uncontrollable movements of your arms, legs, tongue, face, or lips" (possible tardive dyskinesia), or "a painful erection of the penis that lasts for hours." This is not a complete list.

As an atypical antipsychotic, Seroquel (quetiapine) can cause metabolic changes over time: weight gain, high blood sugar that can progress to new-onset diabetes (hyperglycemia), and elevated cholesterol and triglycerides. Reference guidance (StatPearls) is to "monitor the metabolic panel with a specific focus on fasting glucose, cholesterol and triglyceride levels." MedlinePlus notes quetiapine can raise blood sugar even in people without diabetes, so watch for extreme thirst, frequent urination, extreme hunger, or weakness. Regular eye exams are also advised because of a possible link to cataracts.

Yes. Seroquel (quetiapine) can cause orthostatic hypotension — a drop in blood pressure when you stand — which MedlinePlus describes as "dizziness, lightheadedness, and fainting when you get up too quickly from a lying position." This is most likely when starting or increasing the dose; rising slowly helps. Quetiapine can also prolong the QT interval, a change in the heart's electrical rhythm that in rare cases leads to a dangerous arrhythmia (torsades de pointes), so it's used cautiously with other QT-prolonging drugs or in people with existing heart-rhythm issues, sometimes with ECG monitoring. Report fainting, palpitations, or an irregular heartbeat to your doctor.

Sedation, dizziness, and orthostatic lightheadedness usually appear early — within the first days to weeks — and often ease as your body adjusts; metabolic effects like weight gain and blood-sugar changes build up over weeks to months. Do not stop Seroquel (quetiapine) abruptly on your own. MedlinePlus warns that if you suddenly stop, "you may experience withdrawal symptoms such as nausea, vomiting, and difficulty falling asleep or staying asleep," and that "your doctor will probably want to decrease your dose gradually." If you want to stop, talk to your prescriber so the dose can be tapered safely.

Quetiapine (brand name Seroquel) is an atypical antipsychotic FDA-approved to treat schizophrenia and bipolar disorder — including manic episodes, bipolar depression, and long-term maintenance. The extended-release form (Seroquel XR) is also FDA-approved as an add-on treatment for major depression when an antidepressant alone isn't enough. It works by adjusting dopamine and serotonin activity in the brain.

Sometimes, but this is off-label, and it's debated and often discouraged. Low doses of quetiapine cause drowsiness, so it's occasionally prescribed off-label for insomnia — but sleep is not an FDA-approved use. Many clinicians advise against it because even low doses can cause weight gain, metabolic changes, and next-day grogginess, and safer sleep options usually exist. It's also used off-label for anxiety.

Quetiapine carries a boxed warning that it increases the risk of death in older adults with dementia-related psychosis, and it is not approved for that use. Like other antidepressant-related treatments, it also carries the boxed warning about suicidal thoughts in people under 25. Longer term, it can raise blood sugar, cholesterol, and weight, so the FDA label advises monitoring these.